Advertisement
UK markets close in 2 hours 17 minutes
  • FTSE 100

    8,121.46
    +42.60 (+0.53%)
     
  • FTSE 250

    19,783.77
    +181.79 (+0.93%)
     
  • AIM

    754.59
    +1.47 (+0.20%)
     
  • GBP/EUR

    1.1670
    +0.0013 (+0.11%)
     
  • GBP/USD

    1.2509
    -0.0002 (-0.01%)
     
  • Bitcoin GBP

    51,152.01
    +835.52 (+1.66%)
     
  • CMC Crypto 200

    1,382.95
    -13.58 (-0.97%)
     
  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • CRUDE OIL

    84.23
    +0.66 (+0.79%)
     
  • GOLD FUTURES

    2,359.50
    +17.00 (+0.73%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,062.61
    +145.33 (+0.81%)
     
  • CAC 40

    8,053.53
    +36.88 (+0.46%)
     

Shareholders in Trilogy International Partners (TSE:TRL) are in the red if they invested five years ago

We're definitely into long term investing, but some companies are simply bad investments over any time frame. We don't wish catastrophic capital loss on anyone. Anyone who held Trilogy International Partners Inc. (TSE:TRL) for five years would be nursing their metaphorical wounds since the share price dropped 79% in that time.

Since shareholders are down over the longer term, lets look at the underlying fundamentals over the that time and see if they've been consistent with returns.

See our latest analysis for Trilogy International Partners

Trilogy International Partners isn't currently profitable, so most analysts would look to revenue growth to get an idea of how fast the underlying business is growing. Generally speaking, companies without profits are expected to grow revenue every year, and at a good clip. As you can imagine, fast revenue growth, when maintained, often leads to fast profit growth.

ADVERTISEMENT

Over half a decade Trilogy International Partners reduced its trailing twelve month revenue by 5.6% for each year. While far from catastrophic that is not good. The share price fall of 12% (per year, over five years) is a stern reminder that money-losing companies are expected to grow revenue. It takes a certain kind of mental fortitude (or recklessness) to buy shares in a company that loses money and doesn't grow revenue. Fear of becoming a 'bagholder' may be keeping people away from this stock.

You can see how earnings and revenue have changed over time in the image below (click on the chart to see the exact values).

earnings-and-revenue-growth
earnings-and-revenue-growth

We like that insiders have been buying shares in the last twelve months. Having said that, most people consider earnings and revenue growth trends to be a more meaningful guide to the business. This free interactive report on Trilogy International Partners' earnings, revenue and cash flow is a great place to start, if you want to investigate the stock further.

A Different Perspective

We're pleased to report that Trilogy International Partners shareholders have received a total shareholder return of 21% over one year. Notably the five-year annualised TSR loss of 12% per year compares very unfavourably with the recent share price performance. The long term loss makes us cautious, but the short term TSR gain certainly hints at a brighter future. It's always interesting to track share price performance over the longer term. But to understand Trilogy International Partners better, we need to consider many other factors. Take risks, for example - Trilogy International Partners has 3 warning signs we think you should be aware of.

If you like to buy stocks alongside management, then you might just love this free list of companies. (Hint: insiders have been buying them).

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on CA exchanges.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.